Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Struthers Richard Scott Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Exercised 10,000 options to buy @ $1.91, valued at $19.1k
07/13/2023 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 24,384 shares @ $20.14, valued at $491.1k
Sold 11,459 shares @ $20.17, valued at $231.1k
Sold 14,157 shares @ $20.35, valued at $288.1k
07/13/2023 144 Form 144 - Report of proposed sale of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
07/11/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 144 Form 144 - Report of proposed sale of securities:
03/17/2023 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 4,628 shares @ $17.12, valued at $79.2k
10/14/2022 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Exercised 11,100 options to buy @ $1.91, valued at $21.2k
04/15/2022 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 24,674 shares @ $25.4247, valued at $627.3k
Sold 44,793 shares @ $26.5229, valued at $1.2M
Sold 69,176 shares @ $27.5277, valued at $1.9M
04/07/2022 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 21,357 shares @ $25.3418, valued at $541.2k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2022 SC 13G/A Struthers Richard Scott reports a 4.2% stake in Crinetics Pharmaceuticals, Inc.
09/09/2021 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 10,000 shares @ $25, valued at $250k
03/02/2021 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 294,000 options to buy @ $15.29, valued at $4.5M
02/05/2021 SC 13G/A Struthers Richard Scott reports a 5.1% stake in Crinetics Pharmaceuticals, Inc.
12/04/2020 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Bought 1,000 shares @ $12.6, valued at $12.6k
Bought 4,000 shares @ $13.1, valued at $52.4k
07/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $22.61, valued at $4.5M
02/11/2020 5 Struthers Richard Scott (President & CEO) has filed a Form 5 on Crinetics Pharmaceuticals, Inc.
02/11/2020 SC 13G Struthers Richard Scott reports a 6.1% stake in Crinetics Pharmaceuticals, Inc.
08/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2019 4 Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Granted 176,250 options to buy @ $25.19, valued at $4.4M
07/17/2018 3 Struthers Richard Scott (See Remarks) has filed a Form 3 on Crinetics Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy